{
  "id": "73efb28e28c9c9df",
  "title": "AZ and Daiichi Enhertu wins first - in - decade US oncology approval",
  "description": "20251216T124500Z",
  "content": "",
  "source": "europeanpharmaceuticalreview.com",
  "source_url": "https://www.europeanpharmaceuticalreview.com/news/269465/astrazeneca-daiichis-enhertu-first-in-decade-us-oncology-approval/",
  "published_at": "20251216T124500Z",
  "fetched_at": "2025-12-17T00:22:43.797460+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "United Kingdom",
  "raw_data": {
    "url": "https://www.europeanpharmaceuticalreview.com/news/269465/astrazeneca-daiichis-enhertu-first-in-decade-us-oncology-approval/",
    "url_mobile": "",
    "title": "AZ and Daiichi Enhertu wins first - in - decade US oncology approval",
    "seendate": "20251216T124500Z",
    "socialimage": "https://www.europeanpharmaceuticalreview.com/wp-content/uploads/breast-cancer-Palbociclib.jpg",
    "domain": "europeanpharmaceuticalreview.com",
    "language": "English",
    "sourcecountry": "United Kingdom"
  }
}